409 related articles for article (PubMed ID: 37426676)
1. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
Xiao L; Wang Q; Peng H
Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
Wang Y; Wang D; Yang L; Zhang Y
Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
Kumari N; Choi SH
J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
[TBL] [Abstract][Full Text] [Related]
4. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages.
Liang Y; He J; Chen X; Yin L; Yuan Q; Zeng Q; Zu X; Shen Y
Int J Biol Sci; 2023; 19(15):4915-4930. PubMed ID: 37781517
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between tumor-associated macrophages and tumor endothelium: Recent advances in macrophage-based cancer immunotherapy.
Baradaran A; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Shadbad MA; Khosravi N; Derakhshani A; Alemohammad H; Afrashteh Nour M; Safarpour H; Silvestris N; Brunetti O; Baradaran B
Biomed Pharmacother; 2022 Feb; 146():112588. PubMed ID: 35062062
[TBL] [Abstract][Full Text] [Related]
6. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
[TBL] [Abstract][Full Text] [Related]
7. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
8. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy.
Qiao X; Hu Z; Xiong F; Yang Y; Peng C; Wang D; Li X
Lipids Health Dis; 2023 Mar; 22(1):45. PubMed ID: 37004014
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor-associated macrophages in tumor immune evasion.
Huang R; Kang T; Chen S
J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
[TBL] [Abstract][Full Text] [Related]
11. Metabolism in tumour-associated macrophages: a
Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprograming of tumor-associated macrophages.
Puthenveetil A; Dubey S
Ann Transl Med; 2020 Aug; 8(16):1030. PubMed ID: 32953830
[TBL] [Abstract][Full Text] [Related]
14. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages in immunotherapy.
Yan S; Wan G
FEBS J; 2021 Nov; 288(21):6174-6186. PubMed ID: 33492779
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
[TBL] [Abstract][Full Text] [Related]
17. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment.
Anfray C; Ummarino A; Calvo A; Allavena P; Torres Andón F
Methods Mol Biol; 2023; 2614():93-108. PubMed ID: 36587121
[TBL] [Abstract][Full Text] [Related]
19. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
Li L; Ma SR; Yu ZL
Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor-associated macrophages for cancer immunotherapy.
Shu Y; Cheng P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188434. PubMed ID: 32956767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
